Author profile
Murray Trusler, MD, MBA, FCFP, FRRMS,
I read with interest Dr Faye MacKay’s excellent letter to the editor in the May issue of the BCMJ [2025;67:127]. Dr MacKay was justifiably distressed over the abrupt closure of the College of Physicians and Surgeons of... Read More
The new BC Guideline, Atrial Fibrillation—Diagnosis and Management (one of four new guidelines in the Stroke and Atrial Fibrillation series), states: “Patients for whom anticoagulation is recommended for stroke... Read More
Three new oral anticoagulants (NOACs) are now on the market in Canada for use in patients with nonvalvular atrial fibrillation. The agents are dabigatran, rivaroxaban, and apixaban. Standing in the wings awaiting Health... Read More